Multiple Assemblies exist for SMTL entry 5ser
CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 10 IN COMPLEX WITH c1(c(cnn1C)C(=O)N(C)CCF)C(Nc3cc2nc(nn2cc3)c4ccccc4)=O, micromolar IC50=0.0009363; X-RAY DIFFRACTION 2.25 Å

SMTL ID
5ser.1
Ligands
ZINC ION; MAGNESIUM ION; N~4~-(2-fluoroethyl)-N~4~,1-dimethyl-N~5~-[(4S)-2-phenyl[1,2,4]triazolo[1,5-a]pyridin-7-yl]-1H-pyrazole-4,5-dicarboxamide
Polypeptides
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
Oligo-state
monomer
SMTL ID
5ser.2
Ligands
ZINC ION; MAGNESIUM ION; N~4~-(2-fluoroethyl)-N~4~,1-dimethyl-N~5~-[(4S)-2-phenyl[1,2,4]triazolo[1,5-a]pyridin-7-yl]-1H-pyrazole-4,5-dicarboxamide
Polypeptides
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
Oligo-state
monomer
SMTL ID
5ser.3
Ligands
ZINC ION; MAGNESIUM ION; N~4~-(2-fluoroethyl)-N~4~,1-dimethyl-N~5~-[(4S)-2-phenyl[1,2,4]triazolo[1,5-a]pyridin-7-yl]-1H-pyrazole-4,5-dicarboxamide
Polypeptides
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
Oligo-state
monomer
SMTL ID
5ser.4
Ligands
ZINC ION; MAGNESIUM ION; N~4~-(2-fluoroethyl)-N~4~,1-dimethyl-N~5~-[(4S)-2-phenyl[1,2,4]triazolo[1,5-a]pyridin-7-yl]-1H-pyrazole-4,5-dicarboxamide
Polypeptides
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
Oligo-state
monomer